Karolyn Oetjen

Medicine & Life Sciences

1. Acute Myeloid Leukemia 100%
2. Acute Promyelocytic Leukemia 29%
3. Adenocarcinoma 18%
4. AEG 40730 18%
5. Allogeneic Cells 16%
6. Apoptosis 56%
7. Baculoviral IAP Repeat-Containing 3 Protein 16%
8. Bone Marrow 35%
9. Bone Marrow Cells 29%
10. Caspase Activation and Recruitment Domain 34%
11. Chromothripsis 20%
12. Consolidation Chemotherapy 17%
13. Decitabine 36%
14. Dendritic Cells 29%
15. DNA Damage 20%
16. Flow Cytometry 22%
17. Fusariosis 37%
18. Fusarium 15%
19. GATA2 Deficiency 30%
20. Genes 17%
21. Hematology 24%
22. Hematopoiesis 59%
23. Hematopoietic Stem Cells 29%
24. Homologous Transplantation 26%
25. Interleukin-1 23%
26. Ligands 32%
27. Ligases 25%
28. Lung Transplantation 27%
29. Lymphoproliferative Disorders 27%
30. Mesenchymal Stem Cells 17%
31. Mutation 17%
32. Neoplasms 30%
33. Neutropenia 23%
34. Noise 21%
35. pembrolizumab 32%
36. Primary Myelofibrosis 29%
37. Prostate 19%
38. Prostatic Neoplasms 18%
39. Proteogenomics 38%
40. RNA Sequence Analysis 28%
41. T-Lymphocyte Subsets 24%
42. T-Lymphocytes 30%
43. Toll-Like Receptor 1 30%
44. Toll-Like Receptor 2 20%
45. Transgenic Mice 20%
46. Triple Negative Breast Neoplasms 28%
47. Tumor Necrosis Factor Receptor-Associated Peptides and Proteins 24%
48. Ubiquitin 25%
49. Whole Genome Sequencing 18%
50. X-Linked Inhibitor of Apoptosis Protein 30%